NetworkNewsBreaks – CannAssist International Cor
Post# of 77
(Total Views: 219)
Posted On: 02/17/2021 3:22:49 PM
NetworkNewsBreaks – CannAssist International Corporation (CNSC) Featured in Latest Episode of The Bell2Bell Podcast
CannAssist (OTCQB: CNSC), the parent company of Xceptor Labs and developer of innovative CiBiDinol technology, was featured in an episode of The Bell2Bell Podcast, produced by InvestorBrandNetwork (“IBN”) as part of its sustained effort to provide specialized content distribution via widespread syndication channels. Bell2Bell’s latest podcast features Mark Palumbo, founder and CEO of CannAssist, as he discusses the company’s CiBiDinol technology. Palumbo noted that CannAssist’s platform, which was developed as a product of the company’s subsidiary, Xceptor Labs, is capable of improving the performance of CBD and a host of other oil-soluble active ingredients, including non-CBD cannabinoids, terpenes, essential oils and oil-soluble vitamins. He also discussed the company’s business model. “Xceptor Labs uses a B2B business model. We basically can generate a raw material and customize that raw material. We can sell it to other tech houses … and, of course, for the branded companies, we can do it in such a way that we can customize what they’re looking for and help them make the claims that they seek to make,” Palumbo said in the interview. “The other side of the business for us is B2C. We have a brand we call Xceptol. Once we were having the level of success we were with the performance of this product, we really wanted to get it to as many people as we could … to make sure that it was accessible and understandable.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
CannAssist (OTCQB: CNSC), the parent company of Xceptor Labs and developer of innovative CiBiDinol technology, was featured in an episode of The Bell2Bell Podcast, produced by InvestorBrandNetwork (“IBN”) as part of its sustained effort to provide specialized content distribution via widespread syndication channels. Bell2Bell’s latest podcast features Mark Palumbo, founder and CEO of CannAssist, as he discusses the company’s CiBiDinol technology. Palumbo noted that CannAssist’s platform, which was developed as a product of the company’s subsidiary, Xceptor Labs, is capable of improving the performance of CBD and a host of other oil-soluble active ingredients, including non-CBD cannabinoids, terpenes, essential oils and oil-soluble vitamins. He also discussed the company’s business model. “Xceptor Labs uses a B2B business model. We basically can generate a raw material and customize that raw material. We can sell it to other tech houses … and, of course, for the branded companies, we can do it in such a way that we can customize what they’re looking for and help them make the claims that they seek to make,” Palumbo said in the interview. “The other side of the business for us is B2C. We have a brand we call Xceptol. Once we were having the level of success we were with the performance of this product, we really wanted to get it to as many people as we could … to make sure that it was accessible and understandable.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)